Termination by Celldex. Should Celldex elect to terminate the Research Program for all Research Antigens without obtaining an Exclusive Commercial License pursuant to Section 4.3, this Agreement shall immediately terminate, in accordance with the terms of Section 13.4, upon thirty (30) days from the date of Medarex’s receipt of written notice from Celldex of such election.
Appears in 3 contracts
Samples: Research and Commercialization Agreement (Celldex Therapeutics Inc), Research and Commercialization Agreement (Celldex Therapeutics Inc), Research and Commercialization Agreement (Avant Immunotherapeutics Inc)
Termination by Celldex. Should Celldex elect to terminate the Research Program for all Research Antigens without obtaining an Exclusive Commercial License pursuant to Section 4.3, this Agreement shall immediately terminate, in accordance with the terms of Section 13.4, upon thirty (30) days from the date of Medarex’s 's receipt of written notice from Celldex of such election.
Appears in 1 contract
Samples: Research and Commercialization Agreement (Celldex Therapeutics Inc)
